
Fortrea Holdings reported Q1 2026 revenue of $636.5 million with a book-to-bill ratio of 1.15x, marking the third consecutive quarter above 1.1x. Despite a GAAP net loss of $23.6 million, adjusted net income rose to $15.2 million, reflecting improved profitability. The company affirmed its 2026 revenue guidance of $2.55-$2.65 billion and adjusted EBITDA of $190-$220 million, signaling confidence in continued growth and margin expansion. Fortrea also highlighted its new Fortrea Intelligent Technology platform aimed at enhancing clinical trial efficiency.